Nanosphere's Bloodstream Infection Test Designated Moderate Complexity by FDA
November 01, 2012 18:20 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today that it...
Nanosphere to Release Q3 2012 Results and Hold Investor Call on Wednesday, November 7
October 26, 2012 10:43 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere Test Accurately Detects a Broad Panel of Bacterial Targets and Resistance Determinants Directly From Blood Culture
October 22, 2012 10:29 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Nanosphere's (Nasdaq:NSPH) Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) (IUO), based on the company's proprietary array-based...
Nanosphere, Inc. Appoints Roy N. Davis to Board of Directors
October 10, 2012 17:15 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced the...
Nanosphere to Present at Craig-Hallum Alpha Select Conference
September 21, 2012 09:24 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that Roger...
Nanosphere to Present at UBS Global Life Sciences Conference
September 10, 2012 11:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that...
Nanosphere to Present at Rodman & Renshaw Annual Global Investment Conference
August 29, 2012 12:04 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere Announces Second Quarter 2012 Results
August 07, 2012 08:00 ET
|
Nanosphere, Inc.
Gram-positive blood culture test cleared by the FDA on June 27th
Entered into marketing and distribution agreement in Europe with Thermo Fisher Scientific (refer to Nanosphere's April 30th...
Nanosphere to Release Q2 2012 Results and Hold Investor Call on Tuesday, August 7
July 25, 2012 13:10 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 25, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere, Inc. Announces Exercise of Over-Allotment and Closing of Common Stock Offering
July 24, 2012 15:10 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 24, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...